Cypralis Names Michael Peel CSO
This article was originally published in Scrip
Executive Summary
Cypralis Ltd. has appointed as chief scientific officer Michael Peel, who joins the company from Scynexis Inc, where he was director of discovery. Peer has also led research projects in inflammation, cancer and virology at Glaxo Inc. in Research Triangle Park, North Carolina.